Background Genome-wide association studies (GWAS) in Parkinson's disease have increased
the scope of biological knowledge about the disease over the past decade. We aimed to …

Importance Substantial genome-wide association study (GWAS) work in Parkinson disease (PD)
has led to the discovery of an increasing number of loci shown reliably to be associated …

Progressive myoclonus epilepsy of the Lafora type or Lafora disease (EPM2; McKusick no.
254780) is an autosomal recessive disorder characterized by epilepsy, myoclonus, …

Objective: To study EPM2B gene mutations and genotype-phenotype correlations in patients
with Lafora disease. Methods: The authors performed a clinical and mutational analysis of …

The presence of mutations in glucocerebrosidase (GBA) gene is a known factor increasing
the risk of developing Parkinson’s disease (PD). Mutations carriers have earlier disease …

Background Although the leucine‐rich repeat kinase 2 p.G2019S mutation has been
demonstrated to be a strong risk factor for PD, factors that contribute to penetrance among carriers, …

Background The Iberian Peninsula stands out as having variable levels of population admixture
and isolation, making Spain an interesting setting for studying the genetic architecture of …

[Results] QoL was worse in PD patients (n = 692; 62.6 ± 8.9 years old, 60.3% males) than
controls (n = 206; 61 ± 8.3 years old, 49.5% males): PDQ-39, 17.1 ± 13.5 vs 4.4 ± 6.3 (p < …

… Pilar Gomez-Garre contributed to the execution of the research project and reviewed and
critiqued the manuscript. Julia Graf contributed to the execution of the research project and …

Progressive myoclonus epilepsy of Lafora type (LD, MIM 254780) is a fatal autosomal
recessive disorder characterized by the presence of progressive neurological deterioration, …